| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | +87.5% | -55.9% |
| R&D Expense | $28.2M | -19.2% | -28.7% |
| SG&A Expense | $10.7M | +9.2% | -9.2% |
| Operating Income | -$37.3M | +21.0% | +26.2% |
| Net Income | -$38.8M | +9.0% | +12.9% |
| EPS (Basic) | -$2.13 | +26.3% | -1152.9% |
| EPS (Diluted) | -$2.13 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $123.6M | +25.1% | +23.2% |
| Short-term Investments | $196.0M | +10.1% | -42.4% |
| Current Assets | $328.2M | +16.3% | -27.1% |
| Total Assets | $408.0M | +5.8% | -34.1% |
| Current Liabilities | $31.9M | -13.6% | -4.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$117.8M | — | — |
| Capital Expenditures | $476K | — | — |
| Investing Cash Flow | $85.5M | — | — |
| Financing Cash Flow | $50.2M | — | — |
| Free Cash Flow | -$118.2M | — | — |
| +26.3% |
| -1152.9% |
| $78.8M |
| -8.9% |
| -10.9% |
| Stockholders' Equity | $329.1M | +10.1% | -38.0% |